Litcius/Paper detail

COVID‐19 and herpes zoster co‐infection presenting with trigeminal neuropathy

Ana Carolina Andorinho de Freitas Ferreira, Tayla Taynan Romão, Yuri Macedo, Camila Pupe, Osvaldo J. M. Nascimento

2020European Journal of Neurology98 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Varicella-zoster virus (VZV) is a human neurotropic virus that remains in a latent state within ganglionic neurons throughout the entire neuroaxis after the primary infection. When herpes zoster (HZ) leads to trigeminal involvement, the ophthalmic division is the most implicated. COVID-19 has emerged as a viral cause of severe acute respiratory syndrome that has spread all over the world in the last months. Co-infection with COVID-19 and other viruses has been reported, but sparsely, and involving the respiratory viruses. METHODS: The case of a co-infection of COVID-19 with VZV is reported, and the literature reviewed. RESULTS: A 39-year-old immunocompetent man presented with oligosymptomatic infection with COVID-19, which evolved to left facial HZ, affecting the three divisions of the trigeminal nerve. The co-infection was remotely registered, being the respiratory viruses, especially influenza, the most commonly cited association. However, the present case illustrates the emergence of a latent virus infection, which might be favored by the inflammatory response to the former agent (COVID-19). This reaction ascended from the nasal cavity, where trigeminal branches are also placed. CONCLUSIONS: The emergence of latent VZV infection in this rare presentation might illustrate an effect, at least locally, of COVID-19. This virus possibly induced a retrograde reactivation of VZV in a young immunocompetent patient.

Topics & Concepts

MedicineTrigeminal nerveVirusVirologyCoronavirus disease 2019 (COVID-19)Varicella zoster virusRespiratory systemSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyPathologyInternal medicineAnesthesiaDiseaseInfectious disease (medical specialty)Herpesvirus Infections and TreatmentsFacial Nerve Paralysis Treatment and ResearchLong-Term Effects of COVID-19